Eisai Pharmaceuticals
Covid-19 crisis prompts India to look for global partners in health care
Medical devices industry has potential to attract Rs 70,000 crore in 5 years
 "Covid-19 crisis prompts India to look for global partners in health care")
Japanese drug maker Eisai to expand Vizag plant
Eisai Pharmaceuticals plans to expand its manufacturing plant in Visakhapatnam and set up an innovation centre to support its new drug development programmes.The Japanese drug maker sells anti cancer and central nervous disorder drugs in India. It has a manufacturing unit in Visakhapatnam (Vizag) which largely caters for export. The company is now expanding its presence in country with new product launches and is investing in plant expansion."We have a facility to manufacture two billion capsules annually. We are ramping up our active pharmaceutical ingredients (APIs) manufacturing unit and developing an innovation centre for new formulations at Visakhapatnam," said Sanjit Singh Lamba, managing director of Eisai Pharmaceuticals India.The plant has steadily expanded its research and development capabilities and has supplied APIs for two under development drugs to treat hepatic disorders and fungal infections.On Tuesday the company launched its first in class anti-epileptic drug ...
 "Japanese drug maker Eisai to expand Vizag plant")
